Results 151 to 160 of about 724,217 (261)

Taletrectinib in ROS1+ non-small cell lung cancer: a cost-effectiveness analysis in the United States. [PDF]

Front Pharmacol
Huo G, Wang X, Song Y, Tian Y, Chen P.
europepmc   +1 more source

Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS‐CT1 Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau, Marie Bruguet, Irina Viakhireva‐Dovganyuk, François‐Mathias Merrien, Denis Marechal, Aurore Jourdain, Philippe Goas, Jordan Coris, Julien Asselineau, Maëlys Consigny, Gérald Le Gac, Serge Timsit   +11 more
wiley   +1 more source

Cost-Effectiveness Analysis of the High-Dose Trivalent Influenza Vaccine in the Elderly Population in Italy. [PDF]

Clinicoecon Outcomes Res
Panatto D, Bellone M, Castello L, Zanetta L, Piccolo A.   +4 more
europepmc   +1 more source

Baseline Neuroinflammation Stratifies TSPO‐PET Response to Disease‐Modifying Therapy in Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To investigate which baseline clinical and imaging characteristics best predict TSPO‐PET‐measurable reduction in glial activation following treatment of multiple sclerosis (MS), to utilize this information for designing more efficient biomarker‐based clinical trials targeting glial activation.
Marlene T. Morch, Markus Matilainen, Giulia N. Baldrighi, Marjo Nylund, Maija Saraste, Laura Airas   +5 more
wiley   +1 more source

A 10-Year Cost-Effectiveness Analysis of Metabolic and Bariatric Surgery in Adolescents.

JAMA Netw Open
Rode JB, Lim F, Jenkins TM, Ryder JR, Inge TH, Hur C, Teen-LABS Consortium.   +6 more
europepmc   +1 more source

Tuberculosis infection tests for contact screening in Brazil: a cost-effectiveness analysis. [PDF]

Lancet Reg Health Am
Souza F, Steffen R, Pinto M, Nascimento do Prado T, Kritski AL, Trajman A.   +5 more
europepmc   +1 more source

Predictive Value of Composite Inflammatory Markers for Stroke Prognosis: A Prospective Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Novel composite inflammatory markers' role in stroke prognosis is understudied, and the best predictor is unclear, requiring further exploration. Objectives This study aimed to systematically evaluate the associations of 6 novel composite inflammatory markers on stroke prognosis.
Bing Wu, Jie‐Jie Li, Jing Jing, Jin‐Xi Lin, Xia Meng, Yong Jiang, Yong‐Jun Wang, Hong‐Qiu Gu   +7 more
wiley   +1 more source

Cost-Effectiveness Analysis of Ritlecitinib Compared With No Treatment in Patients With Severe Alopecia Areata in Japan. [PDF]

J Dermatol
Yuasa A, Kamei K, Saito S, Mikami M, Murata T, Kurosky SK, Law EH, Nakamura K, Ueki R.   +8 more
europepmc   +1 more source

Deep Learning Pose Estimation for Phenotyping of Co‐Occurring Hyperkinetic Movement Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore whether routine outpatient video combined with deep learning‐based pose estimation and clinically interpretable kinematic features can support multi‐label phenotyping of co‐occurring hyperkinetic movement disorders (HMDs).
Laura Cif, Diane Demailly, Gabriella A. Horvàth, Juan Dario Ortigoza Escobar, Nathalie Dorison, Mayté Castro Jiménez, Cécile A. Hubsch, Thomas Wirth, Gun‐Marie Hariz, Sophie Huby, Morgan Dornadic, Zohra Souei, Muhammad Mushhood Ur Rehman, Simone Hemm, Mehdi Boulaymen, Eduardo M. Moraud, Jocelyne Bloch, Xavier Vasques   +17 more
wiley   +1 more source

Burden of Influenza and Cost-Effectiveness Analysis of Introduction of an Influenza Vaccination Programme Among Older Adults in India. [PDF]

Influenza Other Respir Viruses
Krishnan A, Prabhakaran AO, Shekhawat K, Ortega-Sanchez IR, Kumar R, Amarchand R, Rajkumar P, Kanungo S, Bhardwaj SD, Gopal G, Purushothaman GKC, Potdar V, Chakrabarti AK, Gharpure R, Choudekar A, Lafond KE, Dar L, Saha S, Tan KR, Azziz-Baumgartner E.   +19 more
europepmc   +1 more source